Health Management Model for Pre-Exposure Prophylaxis to the Human Immunodeficiency Virus
Keywords:
gestión en salud; profilaxis pre exposición; infecciones por VIH; modelos de atención de salud; políticas de salud públicaAbstract
Pre-exposure prophylaxis (PrEP) constitutes an effective intervention in the combined prevention of HIV. In Santiago de Cuba, organizational and sociocultural barriers persist that limit its access. A management model was designed and validated to enhance the inclusion and access to PrEP in the municipality of Santiago de Cuba, between July and December 2024. The study included a diagnostic phase and a design phase based on theoretical methods and expert consultation. Validation was performed using Moriyama criteria, applied to 9 specialists selected for their expertise, determined by the Biogram method (K coefficient > 0.8). A systemic model was structured composed of a process management matrix (external) and an areas of incidence matrix (internal), which articulates primary care with multidisciplinary teams. The experts rated the model with the highest score in comprehensibility, justification, and feasibility. The proposed model offers a methodological pathway to decentralize PrEP, focused on the elimination of psychosocial barriers and the training of the basic health team, which ensures the sustainability of the strategy at the primary level.
Downloads
References
1.World Health Organization. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach. Geneva: WHO; 2021 [citado 15/12/2026]. Disponible en: https://www.who.int/publications/i/item/9789240031593
2.ONUSIDA. Informe mundial sobre el sida 2023. El camino que pone fin al sida. Ginebra: ONU; 2023 [citado 24/12/2025]. Disponible en: https://www.unaids.org/sites/default/files/media_asset/2023-unaids-global-aids-update-summary_es.pdf
3.Moreno Soto MF, Delgado Castillo D. Barreras socioculturales de acceso al servicio de profilaxis preexposición al VIH. Rev Electron Dr Zoilo E Marinello Vidaurreta. 2025 [citado 24/12/2025];50:e3862. Disponible en: https://revzoilomarinello.sld.cu/index.php/zmv/article/view/3862
4.Ministerio de Salud Pública de Cuba. Plan Estratégico Nacional para la prevención y el control de las ITS, el VIH y las hepatitis 2024-2028. La Habana: MINSAP; 2023 [citado 24 Dic 2025]. Disponible en: https://temas.sld.cu/vihsida/files/2016/12/Plan-Estrat%C3%A9gico-Nacional-ITS-VIH-hepatitis-2024-2028.pdf
5.Urquiaga Alva, ME. Gestión en salud y la caidad de atención al usuario. Revisión sistematica. Gestio et Productio. Revista Electrónica de Ciencias Gerenciales. 2024[citado 24/12/2025];6(11):218-231. Disponible en: https://iieakoinonia.org/ojs3/index.php/gestioep/article/view/185/285
6.Moriyama IM. Problems in the measurements of health status. En: Eleanor Bernet Sheldon, Wilbert E. Moore. Indicators of social change: Concepts and Measurements. New York: Russell Sage Foundation; 1968 [citado 24/12/2025]. p. 593-612. Disponible en: https://www.russellsage.org/sites/default/files/IndicatorsSocialChange-part1.pdf
7.Castillo AJE, Salamanca CSJ. Educación sanitaria y acceso en farmacoterapia con profilaxis preexposición (PrEP) al VIH, dirigido a grupos de riesgo en Bogotá, Colombia. [tesis]. Bogotá: Universidad El Bosque; 2022 [citado 24/12/2025].46p. Disponible en: https://repositorio.unbosque.edu.co/server/api/core/bitstreams/be8cb4cc-137a-49bd-aea8-d608d8ab314c/content
8.Reichheld A, Torres-Rueda S, Downey L, Mwai D, Kavanagh MM, Ryan O, et al. Barriers and facilitators to scaling up access to HIV pre-exposure prophylaxis among key populations: a qualitative study of the incentive-based PrEP Seguro program in Mexico. SSM Qual Res Health. 2023[citado 24/12/2025];4:100357. Disponible en: https://doi.org/10.1016/j.ssmqr.2023.100357
9.de Souza Lopes C, Lopes Gomes N, Leite Junger W, Rossi Menezes P. Tendencia en la prevalencia de síntomas depresivos en Brasil: resultados de las Encuesta Nacional de Salud de 2013 y 2019. Cad Saude Publica. 2022[citado 15 Feb 2026];38(1):e00123421. Disponible en: https://www.scielo.br/j/csp/a/XBmqFfsR6wbLzMwrKgKG5sp/?lang=en
10. Iniesta C, Coll P, Barberá MJ, García Deltoro M, Camino X, Fagúndez G, et al. Implementation of pre-exposure prophylaxis programme in Spain. Feasibility of four different delivery models. PLoS One. 2021[citado 15/12/2026];16(2):e0246129. Disponible en: https://doi.org/10.1371/journal.pone.0246129
11.Lorenzetti L, Dinh N, van der Straten A, Fonner V, Ridgeway K, Rodolph M, et al. Systematic review of the values and preferences regarding the use of injectable pre-exposure prophylaxis to prevent HIV acquisition. J Int AIDS Soc. 2023[citado 15/12/2026];26(S2):e26107. Disponible en: https://onlinelibrary.wiley.com/doi/epdf/10.1002/jia2.26107
12.Macapagal K, Nery Hurwit M, Matson M, Crosby S, Greene GJ. Perspectives on and preferences for on-demand and long-acting PrEP among sexual and gender minority adolescents assigned male at birth. Sex Res Social Policy. 2020[citado 15/12/2026]; 18(1):39-53. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC7810244/ 13.Organización Panamericana de la Salud. Washington, D.C., EUA: OPS; [citado 15/12/2026]. Atención primaria de salud en las américas: las enseñanzas extraídas a lo largo de 25 años y los retos futuros; [aprox 2p]. Disponible en: https://iris.paho.org/server/api/core/bitstreams/b08de80c-2d07-4e48-8d43-3dd6ece41404/content
14.Urquiaga Alva ME. Gestión en salud y la calidad de atención al usuario. Revisión sistemática. Gestio et Productio. 2024[citado 15/02/2026];6(11):218-31. Disponible en: https://iieakoinonia.org/ojs3/index.php/gestioep/article/view/185/285
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Manuel Felipe Moreno Soto, Dianelys Delgado Castillo , Clemente Couso Seoane
This work is licensed under a Creative Commons Attribution 4.0 International License.
All the articles can be downloaded or read for free. The journal does not charge any amount of money to the authors for the reception, edition or the publication of the articles, making the whole process completely free. Medisan has no embargo period and it is published under the license of Creative Commons, International Non Commercial Recognition 4.0, which authorizes the copy, reproduction and the total or partial distribution of the articles in any format or platform, with the conditions of citing the source of information and not to be used for profitable purposes.
![Secimed](/templates/images/secimed.png"){kind=small}
